Skip to content

Clinical trials

Liver Cirrhosis trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Country / region: Brazil Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20081
20102
20112
20142
20152
20191
20211
20221
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status6
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universidade Federal do Rio de Janeiro3
Hospital Israelita Albert Einstein2
Sanofi2
AstraZeneca1
Atea Pharmaceuticals, Inc.1
Azienda Ospedaliera di Padova1
Boehringer Ingelheim1
European Foundation for Study of Chronic Liver Failure1
Federal University of Minas Gerais1
Hepatopancreatobiliary Surgery Institute of Gansu Province1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis20
Ascites3
Hypertension, Portal3
Non-alcoholic Fatty Liver Disease3
Fibrosis2
Liver Diseases2
Acquired Immunodeficiency Syndrome1
Acute Kidney Injury1
Acute-On-Chronic Liver Failure1
Blind Loop Syndrome1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.